Product Images Fluticasone Propionate And Salmeterol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 22 images provide visual information about the product associated with Fluticasone Propionate And Salmeterol NDC 63629-8810 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
FP chem structure - fluticasone propionate salmeterol inhalation powde 1
Figure 8 - fluticasone propionate salmeterol inhalation powde 10
Teva Logo - fluticasone propionate salmeterol inhalation powde 11
Teva Logo - fluticasone propionate salmeterol inhalation powde 12
Figurr A - fluticasone propionate salmeterol inhalation powde 13
This appears to be a description of a medical device. The device includes a dose counter, a mouthpiece, and a yellow cap. The name "Vent" is also mentioned, which may be the brand name of the device. However, without further context, it is impossible to know what the device is used for or how it operates.*
Figure B - fluticasone propionate salmeterol inhalation powde 14
This text describes the available doses, both full and empty, for an inhaler. The inhaler contains 60 doses when full and has 0 doses when empty.*
Figure C - fluticasone propionate salmeterol inhalation powde 15
Figure C - fluticasone propionate salmeterol inhalation powde 16
Breathe out image - fluticasone propionate salmeterol inhalation powde 17
Figure F - fluticasone propionate salmeterol inhalation powde 18
Figure G - fluticasone propionate salmeterol inhalation powde 19
Salmeterol chem structure - fluticasone propionate salmeterol inhalation powde 2
Figure H - fluticasone propionate salmeterol inhalation powde 20
Teva Logo - fluticasone propionate salmeterol inhalation powde 21
Figure 1 - fluticasone propionate salmeterol inhalation powde 3
Figure 2 - fluticasone propionate salmeterol inhalation powde 4
Figure 3 - fluticasone propionate salmeterol inhalation powde 5
Figure 4 - fluticasone propionate salmeterol inhalation powde 6
This appears to be a table showing data related to inhalers for respiratory treatment, with different dosages and a placebo group. The table includes information about the number of participants tested (N), and the mean change in Forced Expiratory Volume (FEV) over time in liters, with baseline data recorded on Day 1.*
Figure 5 - fluticasone propionate salmeterol inhalation powde 7
Figure 6 - fluticasone propionate salmeterol inhalation powde 8
Figure 7 - fluticasone propionate salmeterol inhalation powde 9
This is a description of a study evaluating the mean change in FEV, or forced expiratory volume, in individuals. The study involved administering doses of FSMDPI at 232 meg/14 mcg and 113 mcg/14 meg, as well as £P MDPI at 232 meg and 113 meg, and a placebo. The number of participants ranged from 58 to 68 per dose. The chart shows the mean change in FEV over the course of 12 hours, with the baseline reading at Day 1 Hour 0.*
Label - lbl636298810
This is a description of Fluticasone Propionate and Salmeterol Inhalation Powder, which is an oral inhaler medication used to treat asthma and COPD. Each inhalation contains 232 mcg of fluticasone proprionate and 14 mcg of salmeterol base. The medication is packaged with 60 metered inhalations and should be stored at room temperature, away from extreme heat, cold or humidity, and should never be put in water. The product is available by prescription only.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.